Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 71Rectal Neoplasms 38Pancreatic Neoplasms 32Colonic Neoplasms 31Neoplasms 29Stomach Neoplasms 22Neoplasm Metastasis 22Carcinoma, Non-Small-Cell Lung 18Esophageal Neoplasms 16Unspecified Adult Solid Tumor, Protocol Specific 15Head and Neck Neoplasms 13Adenocarcinoma 11Squamous Cell Carcinoma of Head and Neck 10Breast Neoplasms 10Ovarian Neoplasms 8Lung Neoplasms 8Lymphoma, Non-Hodgkin 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Renal Cell 6Solid Tumor 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Gallbladder Neoplasms 5Cholangiocarcinoma 5Adenocarcinoma Of Esophagus 5Triple Negative Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Peritoneal Neoplasms 4Melanoma 4Liver Neoplasms 4

Interventions

Gemcitabine 2130-nm albumin-bound paclitaxel 2tislelizumab 1lenvatinib 1ivosidenib 1Positron Emission Tomography Computed Tomography 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pancreatic Ductal Adenocarcinoma × Fluorouracil × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡